Skip to content

Assessment of Serum Concentration of Interleukin-17 and Osteoprotegerin in Response to Surgical Trauma Induced by Management of Mandibular Fractures Via Intraoral Versus Extraoral Approaches: Prospective Cohort Study

Assessment of Serum Concentration of Interleukin-17 and Osteoprotegerin in Response to Surgical Trauma Induced by Management of Mandibular Fractures Via Intraoral Versus Extraoral Approaches: Prospective Cohort Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06349135
Enrollment
2
Registered
2024-04-05
Start date
2024-04-15
Completion date
2025-12-15
Last updated
2024-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mandibular Fractures

Brief summary

Assessment of Serum Concentration of Interleukin-17 and Osteoprotegerin in Response to Surgical Trauma Induced by Management of Mandibular Fractures via Intraoral Versus Extraoral Approaches: Prospective Cohort Study

Interventions

Open Reduction & Internal Fixation of Mandibular fracture either through intraoral or extraoral approaches.

Sponsors

Aya Ayman Ahmed
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Single mandibular fracture. * ORIF is done by two plates fixation with titanium plates and screws. * Age (18-50 years). * Recent fracture (less than 2 weeks).

Exclusion criteria

* Pathological fractures. * Medical compromised patient. * Presence of concomitant injuries. * Patients receive radiotherapy. * Patients receive blood transfusion.

Design outcomes

Primary

MeasureTime frameDescription
IL-176- weeksInterleukin-17
OPG6- weeksOsteoprotegerin

Secondary

MeasureTime frame
Blood Lossin operation room
Operative timeOperative time in minutes

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026